Peroxisomal biogenesis disorder, which has been linked only to lipid metabolism, is also associated with sugar metabolism.
In a study published in Current Biology on June 22, the lab of Professor John Werren at the University of Rochester describes how four closely related species of parasitic wasps change their venoms rapidly in order to adapt to new hosts, and proposes that co-option of single copy genes may be a common but relatively understudied mechanism of evolution for new gene functions, particularly under conditions of rapid evolutionary change.
Exosomes - tiny biological nanoparticles which transfer information between cells - offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded. Areas which could benefit include cancer treatment and regenerative medicine.
New research results from Aarhus University and New York University show how active transport of potassium can be achieved by a membrane protein complex that has roots in both ion pump and ion channel super-families. The results, which have just been published in Nature, shed new light on what define channels and pumps.
A team of researchers from the University of Würzburg has discovered an interesting enzyme in the pathogens responsible for African sleeping sickness: It could be a promising target for drugs.
Biofilms are slimy, glue-like membranes that are produced by microbes in order to colonize surfaces. They protect microbes from the body's immune system and increase their resistance to antibiotics. Biofilms represent one of the biggest threats to patients in hospital settings. But there is good news -- Canadian scientists have developed a novel enzyme technology that prevents the formation of biofilms and can also break them down.
Different types of memories stored in the same neuron of the marine snail Aplysia can be selectively erased, according to a new study by researchers at Columbia University Medical Center (CUMC) and McGill University and published today in Current Biology.
Cleveland Clinic researchers have shown for the first time how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized. Their pre-clinical findings, just published in Cell Chemical Biology, may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer.
Scientists at Berkeley Lab and Michigan State University are providing the clearest view yet of an intact bacterial microcompartment, revealing at atomic-level resolution the structure and assembly of the organelle's protein shell. This work could benefit research in bioenergy and pathogenesis, and it could lead to new methods of bioengineering bacteria for beneficial purposes.
Research from the Stowers Institute provides evidence suggesting that cancer cells might streamline their genomes in order to proliferate more easily. The study, conducted in both human and mouse cells, shows that cancer genomes lose copies of repetitive sequences known as ribosomal DNA. While downsizing might enable these cells to replicate faster, it also seems to render them less able to withstand DNA damage.